# Cefuroxime

## Furoxime inj 1.5gm

| 藥物代碼 | IFUR1 |
| :--- | :--- |
| 適應症 | Infections due to Staphylococci, Streptococci, Pneumococci, Meningococci & other susceptible bacteria. |
| 副作用 | Allergic reactions, GI intolerance, superinfection, eosinophilia. Rarely, transient hematological abnormalities; pseudomembranous colitis, phlebitis. |
| 禁忌 | Hypersensitivity to cephalosporins. |
| 懷孕用藥危分級 | 可能安全 |
| 孕期用藥建議 | N/A |
| 附帶說明 | N/A |
| 哺乳期用藥建議 | No \(Limited\) Human Data - Probably Compatible 無\(很少\)資料 - 可使用 |
| 附帶說明 | AAP: Maternal medication usually compatible with breastfeeding. Micromedex: Infant risk is minimal. Cefuroxime is excreted in breast milk. Manufacturer recommendations vary; caution is recommended if cefuroxime I.V. is given to a nursing woman and it is recommended to consider discontinuing nursing temporarily during treatment following oral cefuroxime. Nondose-related effects could include modification of bowel flora. |
| 注射劑給藥建議途徑 | IM, IV, IVD, IVP, IVPUSH |
| 乾粉稀釋液 | IV:15 mL D/W |
| 輸注點滴液 | 【D10W】 可選 仿單建議  【D5NS】 可選 仿單建議  【D5W】 可選 仿單建議  【L/R】 可選 仿單建議  【N/S】 可選 仿單建議 |
| IVP 用法建議 | 推注時間至少3 ~ 5分鐘 |
| IVD 用法建議 | 給藥濃度1~30mg/mL,滴注時間 &gt; 15~ 60分鐘 |
| 注意事項 | 1. 監測體溫、CBC、腎功能、PT值。 |

